NFKB1 and Sepsis: Cao et al. discovered that a miR-155 blocker could reduce inflammation and restore intestinal barrier function in sepsis-afflicted mice by inhibiting NF-κB signalling [36], indicating that miR-155 might be a proinflammatory mediator in some inflammation-related diseases.